Kiora Pharmaceuticals Investor Relations Material
Latest events
Study Result
Kiora Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Kiora Pharmaceuticals Inc
Access all reports
Kiora Pharmaceuticals Inc is a U.S.-based clinical-stage biopharmaceutical company focused on developing treatments for ophthalmic diseases. The company’s pipeline includes therapies targeting eye conditions such as dry eye disease, retinal disorders, and ocular inflammation. Kiora develops both small molecules and biologics aimed at addressing unmet medical needs in vision care. The company conducts clinical trials and engages in research partnerships to advance its product candidates. Kiora Pharmaceuticals Inc is headquartered in Encinitas, California, and its shares are listed on the NASDAQ.
Key slides for Kiora Pharmaceuticals Inc
Lytham Partners Fall 2024 Investor Conference
Kiora Pharmaceuticals Inc
Lytham Partners Fall 2024 Investor Conference
Kiora Pharmaceuticals Inc
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
KPRX
Country
🇺🇸 United States